Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune

J B Buchanan1, N L Sparkman, R W Johnson

  • 1Laboratory of Integrative Immunology and Behavior, Department of Animal Sciences, University of Illinois Urbana-Champaign, 1207 W. Gregory Drive, Urbana, IL 61801, USA. jessieb@illinois.edu

Insights

Methamphetamine (MA) sensitization impairs the central nervous system's immune response to peripheral signals. This neuroinflammation interference prevents the brain from efficiently responding to immune system challenges in addiction models.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Methamphetamine (MA) use activates microglia and can cause neurotoxicity.
  • MA use is linked to neuroinflammation, impacting the brain's immune environment.
  • MA sensitization models stimulant psychosis and drug addiction.

Purpose of the Study:

  • To investigate if MA sensitization affects thermoregulatory and neuroinflammatory responses to peripheral immune stimuli.
  • To determine how MA sensitization alters the central nervous system's reaction to immune challenges.

Main Methods:

  • C57BL6/J mice received daily MA or saline injections for 5 days to induce behavioral sensitization.
  • Seventy-two hours post-MA, mice were co-administered lipopolysaccharide (LPS) or saline with MA or saline.
  • Blood and brain samples were collected to analyze cytokine mRNA, c-Fos expression, and microglial Iba1 expression.

Main Results:

  • MA sensitization attenuated the central neuroinflammatory response to LPS, while peripheral responses remained unaffected.
  • Plasma cytokine levels increased similarly across groups after LPS administration.
  • MA sensitization reduced LPS- or acute MA-induced microglial Iba1 expression, indicating altered microglial activation.

Conclusions:

  • Methamphetamine sensitization interferes with the central immune response to peripheral immune system signals.
  • The deficit in immune response lies within the central cytokine compartment, not in the periphery-to-brain signaling.
  • MA sensitization prevents the central nervous system from efficiently responding to peripheral immune challenges.